A heat-sensitive liposomal preparation loaded with doxorubicin (multiple brands) was able to deliver its contents directly to liver lesions when the temperature was raised above 39.5 °C by focused ultrasound (FUS), according to a report from researchers at the University of Oxford, United Kingdom. Delivery of doxorubicin to the liver tumors was increased about fourfold by using FUS, and the treatment yielded a response in some patients.
To read the full article, visit: Medscape
A nuclear receptor links HIV drugs with liver disease
Physical activity linked to reduced risk of liver cancer
MICROB-PREDICT – €15 million EU funded microbiome research project kicks off